Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
Tax Provision
Prestige Consumer Healthcare Inc
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
Tax Provision
$10.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Tax Provision
-$3.5B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-8%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Tax Provision
-$400m
|
CAGR 3-Years
43%
|
CAGR 5-Years
16%
|
CAGR 10-Years
-3%
|
|
Pfizer Inc
NYSE:PFE
|
Tax Provision
$1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck & Co Inc
NYSE:MRK
|
Tax Provision
-$1.5B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-4%
|
|
Eli Lilly and Co
NYSE:LLY
|
Tax Provision
-$1.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-1%
|
See Also
What is Prestige Consumer Healthcare Inc's Tax Provision?
Tax Provision
10.1m
USD
Based on the financial report for Dec 31, 2023, Prestige Consumer Healthcare Inc's Tax Provision amounts to 10.1m USD.